1. Catalyst & Ramp-Aware Impact Math

• Nature of Announcement: Tirupati Forge has obtained an Industrial License under the Indian Arms Act, 1959, permitting production of 105mm to 155mm artillery shell bodies with a planned capacity of 150,000 units per annum. Pilot production is targeted for December 2026.
• Order vs. License Reality Check: An industrial license is a necessary regulatory enabler, not a purchase contract. The company currently holds no announced firm order book against this capacity.
• Capacity & Revenue Economics:
• Estimated realization per empty machined shell body (blended across 105mm to 155mm ERFB variants) is approximately ₹18,000 to ₹24,000.
• At 100% capacity utilization (150,000 units), peak potential incremental revenue is roughly ₹270–330 Cr.
• Baseline Run-rate: Q1 FY27 revenue stood at ₹38.1 Cr, yielding an annualized baseline revenue of ~₹150 Cr. Legacy PAT is depressed (~₹5 Cr annualized; Q1 FY27 PAT was ₹1.22 Cr, down 13.6% YoY) due to a 50% US import tariff on exported flanges.
• Year-1 Ramp (FY27): Pilot runs starting Dec 2026 will contribute only trial batch revenues (~₹10–18 Cr, or ~10–12% uplift).
• Steady-State Ramp (FY29): Assuming 60–70% capacity utilization over 3 years, defense revenue adds ~₹180–200 Cr (+120–130% over current baseline).
• Margin Transformation: Commercial forgings yield 3.0–3.5% net margin under US tariff strain. Defence shell machining commands superior margins (8–10% PAT margin). Steady-state PAT from defence could deliver ₹15–18 Cr, nearly tripling the company's total earnings power.

2. Industry Capital Intensity & Growth Horizon

• Capital Intensity: High. Automating precision machining, forging presses, heat treatment lines, and quality verification rigs require substantial up-front capital outlay. Promoters infused ₹21.46 Cr via warrants in September 2026 to fund this capex.
• Execution Difficulty: High. Defense shell bodies endure extreme chamber pressure during firing; metallurgical flaws or minute mass distribution defects cause catastrophic barrel burst or range deviations. Ballistic testing and DGQA approvals represent substantial lead-time hurdles.
• Structural Industry Drivers: Driven by domestic 'Make in India' defense indigenization mandates and worldwide restocking of 155mm artillery ammunition, the addressable sector CAGR stands at 14–18%.

3. Minervini SEPA & Multibagger Quality Review

• ROCE: 8.0% (sub-par, fails standard quality gate; reflective of traditional low-margin flange manufacturing).
• Balance Sheet & Solvency: Debt of ₹42 Cr against Net Worth of ₹133 Cr yields a healthy D/E of 0.32. The warrant issue adds equity cushion.
• Promoter Alignment: Promoter holding stands at 49.42%. Warrants issued at ₹58 (close to market price) signal promoter commitment.
• Momentum vs Fundamentals: The stock has appreciated 75.3% over 12 months, largely pricing in the pivot narrative ahead of underlying earnings delivery.

4. Valuation Scenarios (24–36 Month Horizon)

• Base Case (+45%): Pilot runs in Dec 2026 succeed; company secures initial commercial contracts by mid-2027; reaches 50% capacity by FY29. Total PAT rises from ₹5 Cr to ~₹14 Cr. Valuation normalizes around 25x forward P/E.
• Bull Case (+95%): Swift qualification with Indian MoD and international partners via Brazilian tie-up; 75%+ utilization reached by FY29; US tariff pressures ease on baseline business. Consolidated PAT reaches ₹22 Cr, commanding peer median multiples (32–35x P/E).
• Bear Case (-35%): Prolonged qualification and ballistic trial failures postpone volume production beyond FY28; US duties continue eroding baseline profitability; warrants dilute equity base without immediate top-line absorption.

5. Verdict Rationale

Assigned POSSIBLE with a score of 58. The receipt of the Arms Act license removes a decisive regulatory bottleneck, transitioning the defense pivot from theoretical intent to legal execution. However, the absence of firm procurement orders, an 8% trailing ROCE, tariff headwinds in the core business, and long defense qualification cycles caution against classifying the stock as a 'STRONG CANDIDATE' at this stage.

Tirupati Forge Limited (TIRUPATIFL) - Q1 FY27 Earnings & Defence Pivot Analysis

Analysis Date: 2026-08-13 | Current Price: Rs 65.8 | Sector: Castings & Forgings

1. Industry Context & Capital Intensity

• Industry Structure: Castings and forgings is a highly capital-intensive sector characterized by long gestation cycles, high power and raw material intensity, and intense pricing competition.
• Sector CAGR: Structural growth for industrial and auto forgings is estimated at 9-11% CAGR, while domestic defence component forging exhibits higher potential (15-20% CAGR) driven by indigenisation mandates.
• Execution Difficulty: High. Qualification for defence shell bodies (155mm artillery) requires stringent metallurgical precision, ballistic testing, and batch certifications before full commercial volumes can be recognized.

2. Catalyst & Q1 FY27 Financial Ramp Math

• Quarterly Topline: Q1 FY27 revenue grew 17.9% YoY to Rs 38.10 Cr vs Rs 32.30 Cr in Q1 FY26. Annualised revenue run-rate sits at ~Rs 152 Cr.
• Profitability Squeeze: PAT declined 13.6% YoY to Rs 1.22 Cr, translating to a razor-thin Net Profit Margin of 3.2%. This margin contraction stems from: 1. 50% US import tariffs on key export lines. 2. Higher finance costs (Rs 0.95 Cr vs Rs 0.73 Cr YoY). 3. An exceptional/ECL provision of Rs 1.20 Cr recognized on deposits stuck in a defaulted co-operative bank since 2020.
• Operational PAT (Normalized): Excluding the one-time provision of Rs 1.20 Cr, adjusted PAT is ~Rs 2.42 Cr (6.3% adjusted NPM). While healthier, underlying operational profitability remains vulnerable to tariff and cost pressures.
• Ramp Profile: Production of defence shell bodies commenced in Q1 FY27 with targeted 100% capacity utilization by H2 FY27. Revenue uplift from the defence facility is expected to scale steadily into FY28 rather than providing an instant earnings explosion.

3. Fundamental Quality & Governance Evaluation

• ROCE & Return Metrics: Trailing ROCE stands at a modest 8.0%, falling short of quality thresholds.
• Leverage: Debt is moderate at Rs 42 Cr on Net Worth of Rs 133 Cr (D/E of 0.32). Promoter warrant conversion adds Rs 21.46 Cr in equity buffers.
• Promoter Alignment: Promoters hold 49.42% and subscribed to warrants at Rs 58.
• Governance Concern: The write-down of Rs 1.20 Cr deposited in a defunct co-operative society reflects historical treasury management and risk governance lapses.

4. Valuation & Scenario Calibration

• Price Momentum: The stock has run up 74.2% over the last 6 months to Rs 65.8, pricing in much of the initial defence narrative.
• Bull Case (+55%, Target ~Rs 102): 155mm defence shells achieve rapid domestic and export qualification; defence mix lifts net margin toward 9-10%; annual revenue crosses Rs 220 Cr by FY28 with EPS scaling past Rs 5.0.
• Base Case (+15%, Target ~Rs 76): Steady 18-20% revenue growth; defence ramp partially offsets ongoing US tariff drag; net margin stabilizes around 5-6%; FY28 EPS reaches ~Rs 3.2.
• Bear Case (-35%, Target ~Rs 43): Defence qualification delays, continued 50% US tariff friction, and further provisioning/margin pressure cause multiple de-rating.

5. Verdict Rationale

Tirupati Forge's defence pivot is strategically sound, but trailing fundamentals (8.0% ROCE, 3.2% net margin) and execution risks in defence scaling, combined with recent 74% price appreciation, place the company in the UNLIKELY multibagger tier at current valuations until sustained margin expansion is demonstrated.

Equity Research Report: Tirupati Forge Limited (TIRUPATIFL)

Analysis Date: 2026-08-03 Current Price: ₹70.80 | Market Cap: N/A

1. Catalyst Evaluation & News Impact

On August 3, 2026, Tirupati Forge announced shareholder approval for an increase in authorized capital and preferential issuance of 37,00,000 convertible warrants to promoters at ₹58 per warrant, raising ₹21.46 Cr (~16.1% of net worth).

Freshness Assessment: THIS IS ALREADY PRICED IN. The board approval (July 6), EGM notice (July 7/17), and EGM conclusion (July 31) were previously disclosed. The stock has already run up 112.2% over 6 months and 61.2% over 3 months, reflecting market anticipation of this fundraise for defense expansion. The news impact score is muted (35/100) because it merely confirms regulatory voting outcomes.

2. Industry Context & Ramp-Aware Impact Math

• Industry: Castings & Forgings / Defence Precision Engineering.
• Capital Intensity: High. Automated shell body forge lines and captive solar plants require heavy upfront capital investment.
• Execution Timeline: Defense equipment scaling follows long validation cycles. Production starts Q1 FY27 with target 100% utilization in H2 FY27.

Financial Ramp Projection: * Capital Raised: ₹21.46 Cr. * Expected Year-1 Topline Uplift: ~20% as commercial operations commence in Q1 FY27. * Steady-State Topline Uplift: ~45% upon full capacity utilization in H2 FY27 and defense export ramp. * Margin Profile: Defence forgings offer higher OPM (15-20%) compared to traditional export flanges (where 50% US tariffs squeezed H1 FY26 NPM down to 3.3%). * Steady-State EPS Uplift: ~35% net of warrant dilution.

3. Fundamental Quality & Governance

• ROCE: 8.0% (Fails Quality Gate threshold of 15%).
• Balance Sheet: Debt ₹42 Cr, Net Worth ₹133 Cr, Debt/Equity 0.32.
• Promoter Holding: 49.4% (warrants will marginally increase promoter stake upon conversion).
• Governance Concerns: Issuance of two corrigendums prior to EGM after stock exchange inquiries requires monitoring, though promoter cash infusion is a positive alignment sign.

4. Valuation & Scenario Calibrations

• Bull Case (₹113.0 / +60%): Flawless defense plant ramp, rapid qualification of 155mm shell bodies, and successful Brazilian collaboration offsetting legacy US tariff drag.
• Base Case (₹85.0 / +20%): Defense plant reaches ~70-80% capacity by Q4 FY27, partially buffering legacy export margin compression.
• Bear Case (₹46.0 / -35%): Defence approvals delayed, high power/tariff costs continue to erode legacy forging margins, leading to earnings disappointment post-dilution.

5. Final Verdict & Multibagger Rationale

Verdict: POSSIBLE | Multibagger Score: 42/100 | Confidence: 0.45 While the pivot to 155mm defense shell manufacturing provides a genuine structural catalyst, the news is already priced in after a 112% 6-month rally. Weak trailing ROCE (8.0%) and US tariff headwinds on legacy products dictate caution until Q2 FY27 earnings prove margin expansion.

Executive Summary

Tirupati Forge Limited (TIRUPATIFL) shareholders approved the preferential issuance of 37,00,000 convertible warrants to promoter group entities at Rs 58 per warrant, raising Rs 21.46 crore. Proceeds will fund plant and machinery acquisition for defence shell body production and working capital. The event marks shareholder approval for an earlier announced proposal.

1. Already Priced In Assessment

This shareholder approval follows prior board announcements made across July 2026. The stock has experienced a significant rally (+65.4% over 3 months, +116.5% over 6 months), indicating that the market has already largely priced in the promoter fundraise and defence pivot.

2. Ramp-Aware Financial & Execution Math

• Capital Infusion: Rs 21.46 Cr represents ~16.1% of net worth (Rs 133 Cr) and ~12.9% of FY26 TTM revenue (Rs 165.9 Cr).
• Revenue Ramp: Management expects the defence unit to reach 100% capacity in H2 FY27. Year-1 revenue uplift is projected at ~18% (~Rs 30 Cr incremental revenue), reaching a steady-state uplift of ~35% by FY28.
• EPS Impact: FY26 PAT stood at Rs 6.29 Cr. High-margin defence shells will lift operating margins; however, dilution from 3.7 million warrants and ongoing finance/depreciation charges will moderate equity EPS growth. Steady-state EPS uplift is estimated at ~40%.

3. Business Quality & Macro Risks

• Capital Intensity: Castings & Forgings require substantial equipment investment and carry long working capital cycles.
• ROCE Profile: Trailing ROCE is modest at 8.0% with total debt of Rs 42 Cr.
• Tariff Impact: Margin expansion in defence is partially offset by headwinds in the core export flange business caused by 50% US import tariffs, which compressed Q2 FY26 net margins to 3.3%.

4. Valuation Scenarios (18-24 Month Horizon)

• Base Case (+25%): Defence capacity reaches full operational utilization by H2 FY27, driving FY28 PAT to ~Rs 11.5-12.5 Cr and target price to ~Rs 91.
• Bull Case (+70%): Strong defence export orders combined with partial relief on US tariffs push FY28 PAT to ~Rs 16 Cr, driving target price to ~Rs 125.
• Bear Case (-35%): Slower defence qualification combined with sustained US tariff friction causes earnings disappointment, pulling price down to ~Rs 48.

Conclusion

While the expansion into defence shell manufacturing provides a legitimate structural driver, the market has substantially anticipated this event following a 116% rally over 6 months. Warrant pricing discount and low trailing ROCE (8.0%) warrant a cautious stance. Verdict: POSSIBLE.

1. Industry Context & Capital Intensity

Tirupati Forge operates in the Castings & Forgings industry, which is characterized by high capital intensity, significant depreciation cycles, and sensitivity to raw material (steel) prices. The industry is currently undergoing a structural shift in India, driven by domestic defense indigenization (Aatmanirbhar Bharat). We estimate the structural industry CAGR at 12%, with the defense forging segment growing at a much faster clip (>20%). However, execution difficulty is high due to stringent quality standards, long qualification cycles with defense agencies, and high working capital requirements.

2. Ramp-Aware Catalyst Math & Capital Infusion

The announcement details a Rs 21.46 Cr fundraise via 37 lakh convertible warrants to promoters at Rs 58/share. This represents 16.1% of the company's net worth (Rs 133 Cr). - Dilution & Promoter Alignment: The promoter holding will increase from 49.42% to 50.82% on a fully diluted basis. This is a strong positive signal as promoters are injecting cash near the current market price of Rs 66.9. - Capex Allocation: The funds are earmarked for the defense shell body manufacturing plant. Commercial operations are expected to commence in Q1 FY27 and reach 100% capacity utilization by H2 FY27. - Earnings Impact: Assuming a standard asset turnover of 1.5x on the Rs 21.46 Cr capital, this can generate ~Rs 32 Cr in incremental steady-state revenue. At an estimated defense segment operating margin of 15-18% (substantially higher than their legacy export business which is currently dragged down by a 50% US tariff), this could yield Rs 4.8 - 5.7 Cr in incremental EBITDA, translating to an estimated EPS uplift of Rs 0.8 - 1.1 per share once fully ramped in FY28.

3. Multibagger Quality Assessment

• Strengths: Promoters are actively increasing their stake. The pivot to defense shell bodies addresses the structural weakness of their legacy export business (which is suffering from US tariff barriers).
• Weaknesses: Trailing ROCE is weak at 8.0%. Debt stands at Rs 42 Cr against a Net Worth of Rs 133 Cr (D/E of 0.32). H1 FY26 net profit was down 47.6% YoY to Rs 2.75 Cr due to high depreciation and finance costs. The company must prove execution in the defense sector to achieve a structural re-rating.

4. Valuation & Scenarios (As of 2026-07-17)

• Base Case (45% Upside): Successful ramp-up of the defense unit by H2 FY27, stabilizing margins at 8-10% overall. EPS recovers to Rs 2.5-3.0 by FY28. Applying a conservative multiple of 30x (discounted to peer median of 52.9x due to smaller scale), the target price is ~Rs 90.
• Bull Case (90% Upside): Rapid scale-up of defense orders, margin expansion to >12% as US tariff impacts are fully offset, and ROCE expanding to >15%. EPS reaches Rs 4.0+, leading to a target price of Rs 127.
• Bear Case (-30% Downside): Delays in defense plant execution, continued margin pressure from US tariffs, and high interest costs dragging PAT down. Target price drops to Rs 47.

5. Verdict Rationale

Tirupati Forge is a classic micro-cap turnaround candidate pivoting from a low-margin, tariff-hit legacy business into a high-value defense segment. The promoter warrant allotment provides the necessary capital and aligns incentives. However, due to the lack of recent Mar 2026 quarterly data and the execution risks inherent in defense manufacturing, we classify this as a 'POSSIBLE' multibagger with a score of 58.

1. Industry Context & Capital Intensity

Tirupati Forge operates in the Castings & Forgings industry, which is highly capital-intensive and cyclical. The industry is currently experiencing a structural shift toward domestic defense manufacturing in India, driven by indigenization policies. We estimate a structural industry CAGR of 12%. However, entering defense shell body manufacturing requires substantial upfront capital expenditure, automated machinery, and long qualification cycles with defense agencies. Execution difficulty is high, and gestation periods typically span 18 to 36 months before commercial orders scale.

2. Catalyst Math & Capital Infusion Impact

The announcement details a ₹21.46 Cr fundraise via 37,00,000 convertible warrants issued to promoters at ₹58 per warrant. - Dilution & Capital Structure: The ₹21.46 Cr represents 16.1% of the company's net worth (₹133 Cr). Promoters bring in 25% (₹5.36 Cr) upfront, with the remaining 75% due within 18 months. - Ramp-Aware Execution: The funds are earmarked for the defense pivot. While the company expects 100% capacity utilization of the defense unit by H2 FY27, there is no historical data or current order book to validate the revenue run-rate. Given the lack of TTM revenue data, we cannot compute a precise revenue uplift. However, assuming a typical asset turnover of 1.5x on the new defense capex, the steady-state annual revenue contribution could be around ₹30-32 Cr once fully ramped (likely by FY28).

3. Fundamental Quality & Financial Health

Tirupati Forge exhibits weak fundamental quality as of the analysis date: - ROCE: Extremely low at 8.0%, well below the cost of capital. - Profitability Trend: H1 FY26 Net Profit fell 47.6% YoY to ₹2.75 Cr due to higher depreciation and finance costs. Net profit margins squeezed to 3.3% in Q2 FY26, heavily impacted by a 50% US import duty on its core export business. - Leverage: Debt-to-Equity is manageable at 0.32x (Debt of ₹42 Cr on ₹133 Cr Net Worth), but cash flows are likely stretched given the ongoing capex.

4. Valuation & Scenario Analysis

The stock has run up significantly (12-month return of 58.1%, trading at ₹71.8), which appears to price in the defense narrative ahead of actual execution. - Bull Case (50% Upside): Successful and rapid commercialization of the defense shell body plant by H2 FY27, securing large domestic defense orders, and margin recovery to >8% as defense contribution offsets US export tariff pain. - Base Case (20% Upside): Gradual ramp-up of the defense facility with minor execution delays. Revenue grows moderately, but high depreciation and interest costs keep ROCE depressed below 12% in the medium term. - Bear Case (-30% Downside): Delays in defense certifications, failure to secure meaningful orders, continued margin pressure in the US export market, and equity dilution from warrant conversion dragging down EPS.

5. Verdict Rationale

While the promoter warrant subscription shows commitment, the issuance at an 18% discount to the market price is a minor governance dampener. The company's weak trailing fundamentals (8% ROCE, declining profits) and high vulnerability to US trade barriers make this pivot highly speculative. Until the defense segment demonstrates concrete order wins and margin accretion, a multibagger trajectory is unlikely.

1. Catalyst & Ramp-Aware Impact Math

Tirupati Forge is raising Rs 21.46 Crore through the issuance of 37,00,000 convertible warrants to its promoter group at Rs 58 per share. This represents 16.1% of its current Net Worth (Rs 133 Cr). The pricing of Rs 58 is at an 18% discount to the current market price of Rs 70.7, which is typical for preferential warrants but dilutive in the near term.

The funds are earmarked for the company's strategic pivot into automated defense manufacturing (shell body production). The company expects commercial operations to commence in Q1 FY27 and scale to 100% capacity by H2 FY27.

Because TTM revenue and quarterly P&L data for Mar 2026 are missing, we cannot calculate exact revenue/EPS uplift percentages. However, assuming a typical asset turnover of 1.5x to 2.0x on the new defense capex, the Rs 21.46 Cr capital infusion could eventually generate Rs 32-43 Cr in incremental steady-state revenue. Given that defense shell bodies command higher operating margins than legacy carbon steel flanges (which are currently suffering under a 50% US import tariff), this pivot could structurally re-rate the company's blended operating profit margin (OPM) from the low single digits (3.3% in Q2 FY26) back to 10-12% over the next 24 months.

2. Industry Capital Intensity & Growth Character

The Castings & Forgings industry is highly capital-intensive, requiring continuous reinvestment in tooling, heavy machinery, and automated lines. Execution difficulty is high, particularly when transitioning from commercial automotive/industrial flanges to highly regulated defense-grade shell bodies. The defense forging sector in India is structurally growing, driven by import substitution (Aatmanirbhar Bharat) and export opportunities, with an expected industry CAGR of 12-15% over the next five years.

3. Fundamental Quality & Multibagger Potential

• ROCE: Low at 8.0%, reflecting poor capital efficiency in the legacy business.
• Debt/Equity: Moderate at 0.32 (Debt of Rs 42 Cr vs Net Worth of Rs 133 Cr), leaving some room for leverage if required.
• Promoter Holding: Healthy at 49.75%, with a minor increase over the last two quarters, showing alignment of interest.
• SEPA Grade: C. The legacy business is under severe pressure due to the 50% US import duty, which halved H1 FY26 net profit compared to H1 FY25.

4. Valuation Scenarios (Horizon: 18-24 Months)

• Bull Case (85% Upside to ~Rs 130): Successful commissioning of the automated defense plant in Q1 FY27, rapid ramp-up to 100% capacity by H2 FY27, defense margins of 15%+ offsetting US export tariff headwinds, and a re-rating of the stock's multiple toward the peer median of 30x.
• Base Case (40% Upside to ~Rs 99): Defense plant starts operations with minor delays, reaching 70% capacity utilization by FY27. Blended margins recover to 8%, and the stock experiences moderate re-rating.
• Bear Case (-30% Downside to ~Rs 49): Execution delays in the defense segment, prolonged high tariffs in the US market further eroding legacy margins, and dilution from warrant conversion without corresponding earnings growth.

5. Verdict Rationale

The preferential warrant issue shows strong promoter commitment and provides the necessary capital for a high-margin pivot. However, the lack of recent financial data (Mar 2026 quarter missing) and the low historical ROCE of 8% prevent a 'STRONG_CANDIDATE' rating. The stock is a 'POSSIBLE' multibagger, highly dependent on the timely execution of the defense shell body plant.

1. Ramp-Aware Impact Math

• Fundraise Details: Tirupati Forge is raising ’19.61 Cr via 37,00,000 convertible warrants to promoters at ’53/share (a 22.8% discount to CMP of ’68.7).
• Dilution: Assuming ~13.25 Cr outstanding shares (derived from ’26.5 Cr authorized capital at ’2 FV), the issue of 3.7 million shares represents a ~2.8% dilution.
• Capital Inflow: Staggered structure—only 25% (’4.90 Cr) is upfront, with the remaining 75% (’14.71 Cr) payable over 18 months. This delays the full deployment of capital.
• Revenue & PAT Projection: Assuming an asset turnover of 1.5x on the ’19.61 Cr capex, the peak revenue potential from the defence shell body plant is ~’29.4 Cr. At a projected defence PAT margin of 12% (higher than the core 3.3% due to value-add), the peak PAT contribution would be ~’3.53 Cr.
• Core Business Drag: H1 FY26 PAT was ’2.75 Cr (down 47.6% YoY due to 50% US import duties). Annualizing this gives a core PAT of ~’5.5 Cr. Combined steady-state PAT is estimated at ~’9.03 Cr.
• Valuation Check: Post-dilution shares would be ~13.62 Cr, leading to a steady-state EPS of ~’0.66. At the current price of ’68.7, the forward P/E is ~104x, which is extremely high compared to the peer median P/E of 30.6x. The market has already priced in a flawless execution of the defence pivot.

2. Industry Capital-Intensity & Expected CAGR

• Capital Intensity: HIGH. Castings and forgings require heavy machinery, automated lines, and significant tooling capex.
• Execution Difficulty: HIGH. Entering the defence supply chain involves rigorous qualification, trial orders, and strict quality standards, leading to long gestation periods.
• Expected Industry CAGR: 12.0% for general forgings, though the defence forging segment is growing at 15-20% due to indigenisation push.

3. Multibagger Quality Assessment

• Financials: Trailing ROCE is weak at 8.0%, well below the cost of capital. Net profit margins are squeezed to 3.3% due to US tariff headwinds.
• Debt & Leverage: Debt of ’42 Cr on a net worth of ’133 Cr (D/E of 0.32) is comfortable, but interest costs are already dragging down profitability.
• Promoter Holding: Decent at 49.8%, but the warrant pricing at a 22.8% discount to CMP raises minor governance concerns regarding minority shareholder dilution.

4. Scenario Analysis

• Base Case (+15% upside): Defence plant commences operations in Q1 FY27 and reaches 100% utilization by H2 FY27. Core business stabilizes. High valuation limits further re-rating.
• Bull Case (+45% upside): Rapid scale-up of defence orders with higher-than-expected margins (15%+), leading to EPS of >’0.85 and multiple expansion.
• Bear Case (-35% downside): Delays in defence qualification, further margin deterioration in the core export business due to US tariffs, and delayed warrant conversion.

5. Verdict Rationale

• The fundraise supports a critical strategic pivot into defence, but the stock has already run up 98% in the last 6 months and trades at an astronomical forward multiple. With weak trailing ROCE (8.0%), declining core profits, and a dilutive warrant issue at a steep discount, the risk-reward ratio is unfavorable for a multibagger thesis at current levels.

1. Ramp-Aware Impact Math

• FY26 Base Financials: Revenue of ₹165.94 Cr (₹1,659.4 Mn), PAT of ₹6.29 Cr (₹62.9 Mn). This implies a net profit margin of 3.79%, heavily depressed by expansion costs and the 50% U.S. import duty on exports.
• The Catalyst: A newly commissioned automated defence shell body manufacturing plant with an annual revenue potential of ₹250 Cr (₹2,500 Mn) at 100% capacity, operating at >40% EBITDA margins.
• Year 1 (FY27) Ramp Projection: Commercial production is scheduled to start in Q2 FY27. Assuming a conservative 25% capacity utilization in Year 1 (due to initial trial runs and certification phases), the defence vertical will contribute ₹62.5 Cr. Assuming the legacy business grows at 10% to ₹182.5 Cr, total FY27 revenue is projected at ₹245.0 Cr (+37.7% YoY).
• Steady-State (FY28) Ramp Projection: Assuming 70% capacity utilization in FY28, defence revenue reaches ₹175 Cr. With legacy business at ₹200 Cr, total revenue reaches ₹375 Cr (+126% vs FY26).
• Earnings Impact:
• Legacy business net margin is estimated at 4.0% (₹8.0 Cr PAT on ₹200 Cr revenue).
• Defence business net margin is estimated at 15.0% (accounting for high depreciation and finance costs on the automated plant), yielding ₹26.25 Cr PAT on ₹175 Cr revenue.
• Solar savings add ₹2.0 Cr to PBT (~₹1.5 Cr to PAT).
• Total Steady-State (FY28) PAT is projected at ₹35.75 Cr (₹8.0 + ₹26.25 + ₹1.5), representing a 468% increase over FY26 PAT of ₹6.29 Cr.

2. Industry Capital Intensity & CAGR

• Capital Intensity: HIGH. The castings and forgings industry requires significant upfront capex for automated machinery, presses, and tooling. This is reflected in Tirupati's current debt of ₹42 Cr and the moderation of FY26 PAT due to expansion-related costs.
• Expected Industry CAGR: 12.0%. The sector is benefiting from domestic manufacturing push (Make in India) and structural indigenization in the defence sector, offset by cyclicality in global automotive and industrial exports.

3. Multibagger Quality Assessment

• Financial Health: Trailing ROCE is weak at 8.0%, and debt stands at ₹42 Cr against a net worth of ₹133 Cr (D/E of 0.32). While leverage is manageable, capital efficiency must improve significantly through the high-margin defence vertical to justify a structural re-rating.
• Promoter Alignment: Promoter holding is stable and has ticked up slightly to 49.75% in April 2026, indicating management confidence ahead of the commercial launch.

4. Valuation & Scenarios

• Base Case (120% Upside): Defence production successfully starts in Q2 FY27 and reaches 70% utilization by FY28. PAT rises to ~₹35 Cr. The market re-rates the stock from a low-margin commodity forging multiple to a specialized defence player multiple (25x P/E), leading to substantial upside.
• Bull Case (250% Upside): Rapid ramp-up to 100% capacity utilization by H2 FY27/FY28. Defence EBITDA margins exceed 45%, pushing FY28 PAT past ₹45 Cr. Multiple expands to 35x P/E.
• Bear Case (-30% Downside): Delays in defence commercialization, certification hurdles, or further escalation of U.S. trade barriers on the legacy business. PAT remains stagnant, and high depreciation/interest costs drag down return ratios further.

5. Verdict Rationale

Tirupati Forge is executing a high-stakes, transformational pivot from low-margin commodity forgings to high-value defence manufacturing. The sheer size of the defence capacity (1.5x current revenue) makes this a classic asymmetric bet. However, because the company has historically low ROCE (8.0%) and is entering a highly regulated, high-execution-difficulty sector, we classify this as a POSSIBLE multibagger rather than a strong candidate, pending actual commercial dispatch and margin validation in Q2/Q3 FY27.

1. Ramp-Aware Impact Math

Tirupati Forge reported Q3FY26 revenue of ₹48.60 Cr (up 85.9% YoY) and PAT of ₹2.02 Cr (up 54% YoY). Annualizing this gives a TTM revenue run-rate of ~₹180 Cr and PAT of ~₹7.5-8.0 Cr.

The upcoming 155mm shell body defence plant has an installed capacity of 150,000 units per annum. Assuming a conservative realization of ₹4,000 to ₹5,000 per shell body, the peak revenue potential of this plant at 100% utilization is ₹60-75 Cr. - Year 1 (FY27) Ramp: Management targets 50% utilization by Q1FY27. Assuming an average of 50% utilization for the full year FY27, this translates to ~75,000 units, generating ~₹30 Cr in incremental revenue. This represents a year-1 revenue uplift of ~16.6% over the estimated base. - Steady State (FY28) Ramp: Targeting 80% utilization by FY28, generating ~₹48-50 Cr in incremental revenue, representing a steady-state revenue uplift of ~27-30%. - Margin & EPS Impact: Defence components typically command EBITDA margins of 18-22%, significantly higher than the company's historical margins (which were squeezed to a 3.3% net margin in Q2FY26 due to US duties). Combined with ₹30 Lakhs in quarterly solar energy savings (₹1.2 Cr annually), the blended EBITDA margin is expected to expand by 300-400 bps. At steady state, this defence pivot could add ₹4.5-5.0 Cr to net profit, representing an expected EPS uplift of ~60% over the FY26 base.

2. Industry Capital Intensity & Expected CAGR

The Castings & Forgings industry is highly capital-intensive, requiring continuous reinvestment in tooling, heavy machinery, and automated lines. The industry is currently experiencing a structural tailwind driven by India's defence indigenization push (positive list imports ban) and global supply chain diversification. The domestic defence forging segment is expected to grow at a CAGR of 15-18%, while the general forging industry grows at 10-12%.

3. Multibagger Quality Assessment

• Growth & Acceleration: Q3FY26 shows strong sequential acceleration (PAT up 51% QoQ) and YoY revenue growth of 85.9%, proving that the company is successfully navigating the US tariff headwinds.
• Balance Sheet & ROCE: ROCE is currently mediocre at 12.0%. Debt is manageable at ₹26 Cr against a Net Worth of ₹107 Cr (D/E of 0.24). The recent promoter warrant conversion at ₹32 per share provides growth capital without over-leveraging the balance sheet.
• Promoter Holding: Stable at 48.9%, with recent warrant conversion showing promoter commitment.

4. Valuation & Scenarios

• Base Case (50% Upside): Successful commissioning of the defence plant in March 2026, achieving 50% utilization in FY27. Blended margins improve to 12% EBITDA. Target Price: ₹54.
• Bull Case (110% Upside): Rapid ramp-up to 80% utilization by late FY27, securing direct export orders for shell bodies, and easing of US import duties on the core business. Target Price: ₹76.
• Bear Case (-30% Downside): Delays in defence certifications/orders, prolonged high US tariffs, and margin compression back to 3%. Target Price: ₹25.

5. Verdict Rationale

Tirupati Forge is transitioning from a low-margin commodity forging player exposed to US tariff risks into a specialized defence component manufacturer. While the historical financial metrics (12% ROCE) do not meet the standard high-quality filter, the forward-looking catalyst (commissioning of the automated 155mm shell body plant in March 2026) is highly credible and near-term. Because execution risks in defence are high, we classify this as a 'POSSIBLE' multibagger rather than 'STRONG_CANDIDATE' until commercial off-take from the defence sector is visible in the quarterly numbers.